Financhill
Back

The Chemours Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
44

CC
The Chemours

Last Price:
18.70
Seasonality Move:
1.58%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
44
The Chemours (CC) is a Sell

Is The Chemours a Buy, Sell or Hold?

  • The current The Chemours [CC] share price is $18.70. The Score for CC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CC Stock Price Chart

What is The Chemours's stock price today?

  • The The Chemours share price today is $18.70
    The current trend is relatively stagnant and CC is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 49.63 Sell
Chaikin Money Flow: -898412 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.64 - 19.2) Buy
Bollinger Bands (100): (19.15 - 26.25) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.13 Buy
20-day SMA: 18.4 Buy
50-day SMA: 20.15 Sell
200-day SMA: 25.62 Sell
8-day EMA: 18.39 Buy
20-day EMA: 18.47 Buy
50-day EMA: 19.85 Sell
200-day EMA: 24.39 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

The Chemours Earnings Growth & CC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.39 per share, an increase next quarter of $0.57 per share, a decrease this year of $1.74 per share, and an increase next year of $1.62 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

The Chemours Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):